ALFRED E. TIEFENBACHER (GmbH & Co. KG) Company Profile
AET started out in 1963 as a pioneer in the newly developing international active pharmaceutical ingredient business. In a time when there still was no direct telephone service berween the two countries, the Italian based Recordati became the first principal to be represented exclusively in Germany by AET. Today AET has over 40 best-of-breed suppliers from 13 countries around the globe, from which we can offer top-quality products at highly competitive prices. This classic API business continues to be a cornerstone of our success.
Location
Van-der-Smissen-Straße 1
Hamburg
D - 22767
Germany
Contact
Phone: 49 (0) 40 - 44 18 09 - 0
Fax: 49 (0) 40 - 44 18 09 - 26
Email: info@TIEFENBACHER.com
News Articles
BioXpress Therapeutics, Alfred E. Tiefenbacher GmbH & Co. KG deal
BioXpress, AET BioTech enter agreement to co-develop Adalimumab biosimilar
AET BioTech, the separate biosimilars business within the generic drug developer AET (Alfred E Tiefenbacher) Group and BioXpress Therapeutics SA, a Swiss-based biotechnology company developing monoclo...
AET BioTech and BioXpress to co-develop biosimilar Humira
Plans to develop another biosimilar version of Abbott Laboratories blockbuster rheumatoid arthritis drug Humira (adalimumab) have been announced by AET BioTech, the separate biosimilars business withi...
Alfred Stern Joins Borealis Executive Board
Borealis, a provider of chemical and innovative plastics solutions, announces the appointment of Alfred Stern as Executive Vice President for Polyolefins, effective July 1, 2012. Alfred Stern succeeds...
BioXpress, AET BioTech to co-develop adalimumab biosimilar
BioXpress Therapeutics S.A. (Plan-les-Ouates, Switzerland) and AET BioTech partnered to co-develop a biosimilar version of autoimmune drug adalimumab, a human mAb against tumor necrosis factor (TNF) a...
Alfred Russel Wallace: Evolution's red-hot radical
Sidekick status does Alfred Russel Wallace an injustice. He was a visionary scientist in his own right, a daring explorer and a passionate socialist, argues Andrew Berry.
AET BioTech and BioXpress Therapeutics to Co-Develop Biosimilar Adalimumab
GZIRA, Malta, HAMBURG, Germany and GENEVA, October 30, 2012 /PRNewswire/ -- AET BioTech, the separate biosimilars business within the generic drug developer AET (Alfred E Tiefenbacher) Group and BioX...
Keystone Symposia announces grant from Alfred P. Sloan Foundation
(Keystone Symposia on Molecular & Cellular Biology) Keystone Symposia has received a grant from the Alfred P. Sloan Foundation to fund an advanced life sciences training conference in summer 2013 for...
Drugs and Medications
None
PubMed Articles
Patient rights act : Effect on medical practice.
Evolving psychiatric diagnosis and the DSM: hasten slowly.
Post cardiac arrest syndrome: a review of therapeutic strategies.
Clinical Trials
HIV-HBV Co-Infection and Liver Disease
Human immunodeficiency virus/Hepatitis B virus (HIV/HBV) co-infections are frequently observed due to shared routes of transmission, with reported figures indicating 6-9% of HIV-infected i...
The primary aims of this study are to determine the safety of the RFM System (Alfred Mann Foundation, Santa Clarita, CA) in a patient with incomplete SCI and the effect of the RFM system o...
Exercise Training in Patients With Non-Cystic Fibrosis (CF) Bronchiectasis
The aim of this project is to examine the short and long term effects of an 8 week, twice weekly, outpatient exercise training program for people with bronchiectasis. Participants will be...
Spinal Clearance Study: Expediting the Spinal Clearance Process in the Major Trauma Patient
The Alfred Hospital receives approximately 40% of the major trauma patients in Victoria, all of whom are at risk for spinal injuries. The potential for spinal injuries necessitates the und...
Comparison of Splinting Interventions for Treating Mallet Finger Injuries
Stubbing of the finger-tip is a common injury in sports such as basketball, volleyball, cricket and football. This can result in a Mallet finger deformity, where the end joint of a finger...
Companies
ALFRED E. TIEFENBACHER (GmbH & Co. KG)
AET started out in 1963 as a pioneer in the newly developing international active pharmaceutical ingredient business. In a time when there still was no direct telephone service berween the two countri...
Bioness, Inc. was established in 2004 by three of the world’s leaders in medical technology: the Alfred E. Mann Foundation for Scientific Research, Alfred E. Mann, and NESS Ltd. The Foundation is a...
In 1985 Alfred Mann created the Foundation "to conduct scientific and medical research that may improve the quality of life of people suffering from debilitating medical disabilities by developing inn...
Nil
More Information about "ALFRED E. TIEFENBACHER (GmbH & Co. KG)" on BioPortfolio
We have published hundreds of ALFRED E. TIEFENBACHER (GmbH & Co. KG) news stories on BioPortfolio along with dozens of ALFRED E. TIEFENBACHER (GmbH & Co. KG) Clinical Trials and PubMed Articles about ALFRED E. TIEFENBACHER (GmbH & Co. KG) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ALFRED E. TIEFENBACHER (GmbH & Co. KG) Companies in our database. You can also find out about relevant ALFRED E. TIEFENBACHER (GmbH & Co. KG) Drugs and Medications on this site too.